Prognostic significance and model evaluation of the modified advanced lung cancer inflammation index in locally advanced resectable gastric cancer patients with neoadjuvant chemotherapy
Weidong Xie, Yaoyu Song, Zhaojie Yu, Huanhao Zhang, Shaoliang Han · 2026
Read Prognostic significance and model evaluation of the modified advanced lung cancer inflammation index in locally advanced resectable gastric cancer patients with neoadjuvant chemotherapy by Weidong Xie, Yaoyu Song, Zhaojie Yu, Huanhao Zhang, Shaoliang Han (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13275285.txt.
Description
Weidong Xie and co-authors tested a nutrition and inflammation score as a prognostic marker in stomach cancer in a 2026 retrospective study. Muscle wasting tracks with poor cancer outcomes, but its value after chemotherapy given before surgery was untested. Their score blends blood protein, a blood count ratio, and body mass.
They studied 209 patients with locally advanced stomach cancer who received chemotherapy and then curative surgery. Patients above sex specific score cutoffs lived longer, and the link held after adjustment and in checks with alternate methods. Higher quartiles showed a steady protective trend. A chart model built on the score predicted survival with fair accuracy and added value beyond stage and regimen data. The authors say outside validation must come before clinical use.
Catalog record
| CREATOR | Weidong Xie, Yaoyu Song, Zhaojie Yu, Huanhao Zhang, Shaoliang Han |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 26 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |